Rejoinder: response-adaptive randomization in clinical trials (Q6111470): Difference between revisions

@@ Property / cites work @@
+Q4184154
@@ Property / cites work: Q4184154 / rank @@
+Normal rank
@@ Property / cites work @@
+Optimal adaptive randomized designs for clinical trials
+Normal rank
@@ Property / cites work @@
+Q4264744
@@ Property / cites work: Q4264744 / rank @@
+Normal rank
@@ Property / cites work @@
+Using a dose‐finding benchmark to quantify the loss incurred by dichotomization in Phase II dose‐ranging studies
+Normal rank
@@ Property / cites work @@
+Response-adaptive randomization in clinical trials: from myths to practical considerations
+Normal rank
@@ Property / cites work @@
+Bayesian adaptive bandit-based designs using the Gittins index for multi-armed trials with normally distributed endpoints
+Normal rank
@@ Property / cites work @@
+Bayesian Response-Adaptive Designs for Basket Trials
+Normal rank
@@ Property / cites work @@
+Multi-armed bandit models for the optimal design of clinical trials: benefits and challenges
+Normal rank
@@ Property / cites work @@
+Response‐adaptive randomization for multi‐arm clinical trials using the forward looking Gittins index rule
+Normal rank
@@ Property / cites work @@
+A Bayesian adaptive design for clinical trials in rare diseases
+Normal rank
@@ Property / cites work @@
+Bayesian doubly adaptive randomization in clinical trials
+Normal rank